Key facts
- HydroCision’s last known valuation is $20.2M (Apr 2025).
- It has raised $18.7M across 2 recorded rounds; the latest was Seed Round ($2.5M) in Nov 2024.
- Notable investors include BioVentures Investors, Volcano Capital.
- HydroCision has filed 4 Form Ds with the SEC since 2009, most recently Apr 2025 ($2.5M sold to 12 investors).
- Status: Privately Held (backing).
Investors
2- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for HydroCision
Funding rounds
2 roundsAbout HydroCision
Operator of a medical device company intended to focus on the commercialization of proprietary fluidjet technology. The company offers services to improve surgical outcomes by adapting water-jet technology to various medical applications, controlling a hair-thin, high-pressure stream of sterile saline to selectively resect and remove tissue of various densities from a surgical site in a minimally invasive manner, enabling clinical and economic outcomes in multiple fields of surgery.
- Sector
- Healthcare
- HQ
- North Billerica, MA, United States
- Founded
- 1996
- Employees
- 31
- Website
- hydrocision.com/
- Ownership
- Privately Held (backing)
HydroCision doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in HydroCision shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on HydroCision in its N-PORT filings yet. We sweep new filings monthly.